IL6 and colitis: CPP1-2-1, on the other hand, reduces the expression of TLR4, NF-κB, TNF-α, and IL-6 in LPS-induced RAW264.7 cells in a dose-dependent manner and alleviates DSS-induced pathological injury in mice with colitis [40].